Immediate Impact

2 by Nobel laureates 10 from Science/Nature 56 standout
Sub-graph 1 of 21

Citing Papers

Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
2 intermediate papers

Works of DA Berry being referenced

Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance)
2016
Abstract S5-01: Impact of the addition of carboplatin (Cb) and/or bevacizumab (B) to neoadjuvant weekly paclitaxel (P) followed by dose-dense AC on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
DA Berry 298 203 97 209 7 628
D. A. Berry 249 298 46 66 26 655
Y Wang 99 263 124 119 8 593
Paula Kim 155 219 134 46 12 611
John D. Cook 80 80 43 414 19 695
Jeanne Fourie Zirkelbach 100 259 211 48 14 533
Kourosh Parivar 31 175 62 161 20 631
Melisa Tucker 118 350 297 70 13 549
Heiko Götte 46 358 472 100 23 735
Bill Poland 136 242 373 52 14 659
Tracy Lively 248 141 120 69 17 570

All Works

Loading papers...

Rankless by CCL
2026